Anti-inflammatory peptides and use thereof
US9346854B2 · kind B2 · utility
2Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2014 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Jul 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated peptides of 13-30 amino acids comprising 5-9 consecutive repeats of the amino acid pair Alanine-Leucine or Alanine-Valine are provided. The peptides further comprise a stretch of 1-3 Lysine residues present at least at one of the peptide's termini, wherein the only Lysine residue in the isolated peptide is present at the stretch of 1-3 Lysine residues. Pharmaceutical compositions comprising same, methods of treating inflammatory conditions and allergic reactions, as well as methods of neutralizing the activity of lypopolysaccharides are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.